article thumbnail

Retail, Tech Get New Life In Burgeoning Economy

PYMNTS

And Omega Advisors sold all of its position in Netflix, opting to add new holdings in biotechnology companies including Madrigal Pharmaceuticals and Deciphera Pharmaceuticals. percent gain in the benchmark S&P 500 index. However, it increased its stake in Microsoft by nearly 310 percent, acquiring 1.7 million shares.

Retail 40
article thumbnail

Walmart+ And Amazon Prime Face Off As Consumers Decide Who Gets Their Business

PYMNTS

The acquisition of PillPack put Amazon in the online pharmaceutical business, and its addition of product insurance and extended warranties put it into the insurance business. Taking Q2 numbers as the benchmarks for now (we won’t have Walmart’s Q3 until it reports earnings on Nov. Take sporting goods.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Transcript: David Conrod – The Big Picture

CFO News Room

So, you have the headquarters of a big pharmaceutical company, and they — they’re looking to raise some cash, maybe not a pharmaceutical company, but some other business. CONROD: I — I think the — in this low interest rate environment people are looking for yield and income, and how do they — they have a — they have a benchmark.

article thumbnail

Transcript: Joel Tillinghast, Fidelity

Barry Ritholtz

He has absolutely crushed his benchmark over that period. He’s crushed the Russell 2000, whatever benchmark you want to talk about. You’re 34th, you’re retiring after 34 years and you trounce what’s really the more appropriate benchmark, I would assume the Russell 2000. a year since 1989. Much better.

article thumbnail

Transcript: Richard Bernstein

Barry Ritholtz

BERNSTEIN: I was a maintenance guy in a pharmaceutical plant. You know, if you look at the data, they say, oh, we’re active managers, but maybe they changed duration from 92 percent of benchmark to 94 percent of benchmark duration. RITHOLTZ: — taken into as poorly as the benchmark. RITHOLTZ: Oh, really?